These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 25934656)

  • 1. China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China.
    Gao P; Zhao Z; Wang D; Wu J; Cai Y; Li T; Wu W; Shi H; He W; Zhu F; Jiao L; Ling F
    Interv Neuroradiol; 2015 Apr; 21(2):196-204. PubMed ID: 25934656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
    Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L;
    JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.
    Chimowitz MI; Lynn MJ; Turan TN; Fiorella D; Lane BF; Janis S; Derdeyn CP;
    J Stroke Cerebrovasc Dis; 2011; 20(4):357-68. PubMed ID: 21729789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter Prospective Trial of Stent Placement in Patients with Symptomatic High-Grade Intracranial Stenosis.
    Gao P; Wang D; Zhao Z; Cai Y; Li T; Shi H; Wu W; He W; Yin L; Huang S; Zhu F; Jiao L; Ji X; Qureshi AI; Ling F
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1275-80. PubMed ID: 26869472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective Phase I study.
    Dumont TM; Sonig A; Mokin M; Eller JL; Sorkin GC; Snyder KV; Hopkins LN; Levy EI; Siddiqui AH
    J Neurosurg; 2016 Oct; 125(4):964-971. PubMed ID: 26745485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
    Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ;
    Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CASSISS Randomized Clinical Trial.
    Turan TN; Psychogios MN
    Stroke; 2023 Jan; 54(1):286-289. PubMed ID: 36367102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis.
    Zaidat OO; Castonguay AC; Fitzsimmons BF; Woodward BK; Wang Z; Killer-Oberpfalzer M; Wakhloo A; Gupta R; Kirshner H; Eliasziw M; Thomas Megerian J; Shetty S; Yoklavich Guilhermier M; Barnwell S; Smith WS; Gress DR;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1131-9. PubMed ID: 23261207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ;
    Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China.
    Wang Y; Miao Z; Wang Y; Zhao X; Gao P; Liu L; Wang F; Liu Y; Ma N; Xu Z; Mo D; Gao F;
    BMJ Open; 2014 Aug; 4(8):e005175. PubMed ID: 25107437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial angioplasty and stent placement after stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial: present state and future considerations.
    Qureshi AI; Al-Senani FM; Husain S; Janjua NA; Lanzino G; Lavados PM; Nguyen T; Raymond J; Shah QA; Suarez JI; Suri MF; Tolun R
    J Neuroimaging; 2012 Jan; 22(1):1-13. PubMed ID: 22250951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioplasty and stenting for patients with symptomatic intracranial atherosclerosis: study protocol of a randomised controlled trial.
    Cui XP; Lin M; Mu JS; Ye JX; He WQ; Fu ML; Li H; Fang JY; Shen FF; Lin H
    BMJ Open; 2016 Nov; 6(11):e012175. PubMed ID: 27852711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study.
    Mazighi M; Tanasescu R; Ducrocq X; Vicaut E; Bracard S; Houdart E; Woimant F
    Neurology; 2006 Apr; 66(8):1187-91. PubMed ID: 16636236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?
    Lutsep HL; Lynn MJ; Cotsonis GA; Derdeyn CP; Turan TN; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI;
    Stroke; 2015 Nov; 46(11):3282-4. PubMed ID: 26382173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial.
    Derdeyn CP; Chimowitz MI
    Neuroimaging Clin N Am; 2007 Aug; 17(3):355-63, viii-ix. PubMed ID: 17826637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients.
    Yu SC; Leung TW; Lee KT; Wong LK
    J Neurointerv Surg; 2014 Apr; 6(3):212-8. PubMed ID: 23516268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of qualifying artery on the efficacy of stenting plus medical therapy versus medical therapy alone in patients with symptomatic intracranial stenosis: a post-hoc analysis of the CASSISS trial.
    Wu Q; Wang J; Zheng B; Qi J; Xu S; Wu P; Zhang G; Ji Z; Wang C; Yao J; Jiao L; Gao P; Wang T; Wang D; Li T; He Y; Zhao Z; Cai Y; Wu W; He W; Shi H; Li Y;
    J Neurointerv Surg; 2024 Jun; 16(7):663-669. PubMed ID: 37438104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.